Intrinsiqs

Is Evommune, Inc. overvalued?

Evommune, Inc. (EVMN) — key valuation metrics and fundamentals.

No verdict
Price
$14.65
Fair value
Current P/E
Normal P/E
Market cap
$531.7M
Dividend yield
0.0%
Return on equity
-62.6%
Sector
Healthcare

See the full interactive analysis →

Fair value compares EVMN's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.